|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
SCIDIR_on1303558804 |
| 003 |
OCoLC |
| 005 |
20231120010636.0 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
220315s2022 enk o 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d OCLCO
|d OCLCF
|d LML
|d OCLCQ
|d N$T
|d OCLCO
|
| 019 |
|
|
|a 1303671743
|
| 020 |
|
|
|a 9780323898010
|q (electronic bk.)
|
| 020 |
|
|
|a 0323898017
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323855440
|
| 035 |
|
|
|a (OCoLC)1303558804
|z (OCoLC)1303671743
|
| 050 |
|
4 |
|a RC365
|
| 082 |
0 |
4 |
|a 616.84061
|2 23
|
| 245 |
0 |
0 |
|a Nanomedical drug delivery for neurodegenerative diseases
|h [electronic resource] /
|c edited by Awesh K. Yadav, Rahul Shukla and S.J.S. Flora.
|
| 260 |
|
|
|a London, UK :
|b Academic Press,
|c 2022.
|
| 300 |
|
|
|a 1 online resource
|
| 500 |
|
|
|a Includes index.
|
| 650 |
|
0 |
|a Nervous system
|x Degeneration
|x Chemotherapy.
|
| 650 |
|
0 |
|a Drug delivery systems.
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
2 |
|a Drug Delivery Systems
|0 (DNLM)D016503
|
| 650 |
|
2 |
|a Nanomedicine
|0 (DNLM)D050997
|
| 650 |
|
6 |
|a Syst�emes d'administration de m�edicaments.
|0 (CaQQLa)000260397
|
| 650 |
|
6 |
|a Nanom�edecine.
|0 (CaQQLa)201-0448752
|
| 650 |
|
7 |
|a Drug delivery systems
|2 fast
|0 (OCoLC)fst00898667
|
| 650 |
|
7 |
|a Nanomedicine
|2 fast
|0 (OCoLC)fst01744350
|
| 700 |
1 |
|
|a Yadavm Awesh K.,
|e editor
|
| 700 |
1 |
|
|a Shukla, Rahul,
|e editor
|
| 700 |
1 |
|
|a Flora, S. J. S.,
|e editor
|
| 776 |
0 |
8 |
|i Print version:
|z 9780323898010
|
| 776 |
0 |
8 |
|i Print version:
|z 032385544X
|z 9780323855440
|w (OCoLC)1263867218
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323855440
|z Texto completo
|
